Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bliss

Showing results (301-310 of 378) with videos related to

Pageof 38
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2020
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in MiceAlec W Freyn, Jamile Ramos da Silva, Victoria C Rosado, et al.
Breast Cancer Research : BCR|April 3, 2016
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomasElena López-Knowles, Qiong Gao, Maggie Chon U Cheang, et al.
Cancer Discovery|November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast CancerBelinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer GroupR C Coombes, J M Bliss, J Wils, et al.
Pediatric Research|April 29, 2026
Neonatal sepsis and cardiovascular dysfunction II: assessmentSophie M Duignan, Satyan Lakshminrusimha, Kathryn Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancerR Charles Coombes, Judith M Bliss, Marc Espie, et al.
The Lancet. Oncology|September 24, 2013
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsJoanne S Haviland, J Roger Owen, John A Dewar, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury in Hyperglycemic Stroke: Key Roles for Luminal Glycocalyx and ComplementHansen Chen, Jacqueline A Frank, Chunfeng Tan, et al.
Brain : a Journal of Neurology|December 20, 2015
Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic targetTakeshi Hiu, Zoya Farzampour, Jeanne T Paz, et al.
The Lancet. Oncology|June 14, 2025
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialAnna M Kirby, Laura Finneran, Clare L Griffin, et al.
Pageof 38

Showing results (301-310 of 378) with videos related to

Sort By:
Pageof 38
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2020
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in MiceAlec W Freyn, Jamile Ramos da Silva, Victoria C Rosado, et al.
Breast Cancer Research : BCR|April 3, 2016
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomasElena López-Knowles, Qiong Gao, Maggie Chon U Cheang, et al.
Cancer Discovery|November 20, 2023
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast CancerBelinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer GroupR C Coombes, J M Bliss, J Wils, et al.
Pediatric Research|April 29, 2026
Neonatal sepsis and cardiovascular dysfunction II: assessmentSophie M Duignan, Satyan Lakshminrusimha, Kathryn Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancerR Charles Coombes, Judith M Bliss, Marc Espie, et al.
The Lancet. Oncology|September 24, 2013
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsJoanne S Haviland, J Roger Owen, John A Dewar, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury in Hyperglycemic Stroke: Key Roles for Luminal Glycocalyx and ComplementHansen Chen, Jacqueline A Frank, Chunfeng Tan, et al.
Brain : a Journal of Neurology|December 20, 2015
Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic targetTakeshi Hiu, Zoya Farzampour, Jeanne T Paz, et al.
The Lancet. Oncology|June 14, 2025
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialAnna M Kirby, Laura Finneran, Clare L Griffin, et al.
Pageof 38